ResearcherJilin UniversityNo recent work listed
Min Liang
Matched on ORCID iD 0000-0002-6348-0043; OpenAlex author ID A5018331471.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Collaborators
- 3
2017: 1 paper · 2018: 1 paper
Papers 2
- CHK1 inhibition sensitizes pancreatic cancer cells to gemcitabine via promoting CDK-dependent DNA damage and ribonucleotide reductase downregulation. First author DOI 10.3892/or.2017.6168↗
- Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, STAT3 and ERK signaling. Co-author DOI 10.18632/oncotarget.21704↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Yingjie Guo · 2 shared papers, 2017–2018
- Paper CHK1 inhibition sensitizes pancreatic cancer cells to gemcitabine via promoting CDK-dependent DNA damage and ribonucleo… DOI 10.3892/or.2017.6168↗
- Paper Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, … DOI 10.18632/oncotarget.21704↗
- Limei Zhao · 1 shared paper, 2017
- Jingkai Zhou · 1 shared paper, 2017
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.